ArticleBMC rheumatology2026
Radiographic outcome over 15 years in patients with early rheumatoid arthritis - a BARFOT-study.
Article in BMC rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo investigate the progression of radiographic damage in hands and feet of patients with early rheumatoid arthritis monitored prospectively for 15 years, and to search for predictors.
methodsThis study comprises 990 patients from the BARFOT cohort, included 1992-2006. Radiographs of the hands and feet were performed over time and evaluated by the Sharp van der Heijde scoring (SHS) method. The patients were divided into three clusters, using progression over 15 years of erosion score and joint space narrowing score. The cluster analyses were conducted using K-means cluster analysis. Disease activity was measured by Disease Activity Score 28 (DAS28) and erythrocyte sedimentation rate (ESR), and physical function by Health Assessment Questionnaire (HAQ).
resultsCluster 1 consisted of 54, cluster 2 of 258 and cluster 3 of 678 patients. Of the patients with the highest radiographic progress during the 15 years (cluster 1), 59% were included in the 1990s, and they were overall more often seropositive (94%), and had at baseline higher SHS, and lower DAS28. Of the patients with the smallest radiographic progression (cluster 3), 45% were included in the 1990s, and they were overall less often seropositive, had at baseline lower SHS, higher DAS28 and higher tender joint count (TJC). At baseline, there was no difference in the choice of treatment between the clusters. From the two-year follow-up, a higher proportion of patients in cluster 3 were untreated. Seropositivity and less tender joints predicted belonging to cluster 1, whereas besides seropositivity also older age, female sex, and erosions at baseline predicted belonging to cluster 2. The worse radiographic progression in cluster 1 and 2 was associated with higher DAS28 throughout the 15 years, and with worse HAQ at both 8 and 15 years, compared with cluster 3.
conclusionsThis study highlights the presence of distinct subgroups of rheumatoid arthritis, which points to the importance of early and individualised treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.